CCIA's research takes a multi-pronged and solutions-oriented approach to childhood cancer. We are studying everything from what causes childhood cancer, to treating it more effectively, to ensuring survivors have the best possible quality of life.

Understanding cancer in kids

Cancer in children is not the same as cancer in adults. For example, while adult cancer is often related to exposure to an environmental factor (e.g. cigarette smoke), childhood cancer most often is not. Learn more about this research here:

Cancer Cell Development Group
Molecular Carcinogenesis Program

Diagnosing cancer better

For the best chance of survival, it is vital that cancer in a child is detected as early as possible and the best treatment plan is worked out. We are working on developing better methods of diagnosis as well as "risk assessment", so treatment can be tailored to the individual. Learn more about this research here:

Molecular Diagnostics Program
Minimal Residual Disease (MRD) Group

Improving treatment

In the past, children with cancer have often had to be treated with adult cancer drugs because that's all that has been available. Much of our research is focused on developing treatments for children that are more effective, with fewer side effects. Find out more here:

ACRF Drug Discovery Program
Experimental Therapeutics Program
Leukaemia Biology Program
Tumour Biology and Targeting Program
Histone Modification Group

A better life for survivors

Childhood cancer and its treatment can lead to long-term health problems in survivors. These are often called "late effects" because they only become apparent over time. Through research we are learning more about late effects and how they can be minimised, to ensure the best possible quality of life for survivors. Find out more here:

Long Term Follow Up Project